Talphera (TLPH) Cash & Equivalents (2010 - 2026)
Talphera's Cash & Equivalents was $742,000 in Q2 2026, down 89.1% from $6.79 million a year earlier and down 80.6% from the prior quarter.
Powered by 
Analysis
Talphera (TLPH) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Talphera came in at $5.89 million, down 33.5% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -23.3% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $8.86 million in FY2024 (+54.9%), $5.72 million in FY2023 (-62.5%), $15.28 million in FY2022 (+99.3%) and $7.66 million in FY2021 (-65.6%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents in data going back to Q2 2010.
- Compared with a year earlier, Cash & Equivalents has declined for six straight quarters, with an average decline of 35.9% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2022 (growth of 99.3%); the worst was Q2 2026 (a decline of 89.1%).
- Per Business Quant data, TLPH's Cash & Equivalents in the three quarters before Q2 2026 was $3.82 million (Q1 2026), $5.89 million (Q4 2025) and $3.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Talphera | 79.30 Mn | 62.23 Mn | - | 742,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 742,000.00 |
| Mar 31, 2026 | 3.82 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | 6.79 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Sep 30, 2024 | 11.12 Mn |
| Jun 30, 2024 | 13.42 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Sep 30, 2023 | 13.39 Mn |
| Jun 30, 2023 | 7.41 Mn |
| Mar 31, 2023 | 13.35 Mn |
| Dec 31, 2022 | 15.28 Mn |
| Sep 30, 2022 | 12.73 Mn |
| Jun 30, 2022 | 15.17 Mn |
| Mar 31, 2022 | 21.82 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 8.27 Mn |
API Access
Talphera Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TLPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TLPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TLPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();